Cargando…

Association of CRISPR/Cas System with the Drug Resistance in Klebsiella pneumoniae

BACKGROUND: Klebsiella pneumoniae is a common opportunistic pathogen and its production of extended-spectrum β-lactamases (ESBL) and carbapenemases leads to drug resistance. Clustered regularly interspaced short palindromic repeats (CRISPRs) and their associated genes (Cas) are widespread in the gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Song, Guobin, Xu, Yuanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320894/ https://www.ncbi.nlm.nih.gov/pubmed/32606841 http://dx.doi.org/10.2147/IDR.S253380

Ejemplares similares

CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae
por: Kamruzzaman, Muhammad, et al.
Publicado: (2020)

A Rapid Antimicrobial Susceptibility Test for Klebsiella pneumoniae Using a Broth Micro-Dilution Combined with MALDI TOF MS
por: Wang, Gang, et al.
Publicado: (2021)

CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae
por: Mackow, Natalie A., et al.
Publicado: (2019)

An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant Klebsiella pneumoniae
por: McConville, Thomas H., et al.
Publicado: (2021)

Exploiting a conjugative endogenous CRISPR-Cas3 system to tackle multidrug-resistant Klebsiella pneumoniae
por: Zhou, Ying, et al.
Publicado: (2023)

Characterization of CRISPR-Cas Systems in Clinical Klebsiella pneumoniae Isolates Uncovers Its Potential Association With Antibiotic Susceptibility
por: Li, Hsin-Yu, et al.
Publicado: (2018)

The type I-E CRISPR-Cas system influences the acquisition of bla(KPC)-IncF plasmid in Klebsiella pneumonia
por: Zhou, Ying, et al.
Publicado: (2020)

Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae
por: Ostria-Hernández, Martha Lorena, et al.
Publicado: (2015)

Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae
por: Jwair, Noor A., et al.
Publicado: (2023)

Detection of Klebsiella pneumonia DNA and ESBL positive strains by PCR-based CRISPR-LbCas12a system
por: Wang, Shang, et al.
Publicado: (2023)

Epidemiological and Antimicrobial Resistant Patterns, and Molecular Mechanisms of Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU Patients
por: Lu, Fanbo, et al.
Publicado: (2023)

A Global Comprehensive Study of the Distribution of Type I-E and Type I-E* CRISPR-Cas Systems in Klebsiella pneumoniae
por: Kannadasan, Anand Babu, et al.
Publicado: (2023)

Engineering CRISPR interference system in Klebsiella pneumoniae for attenuating lactic acid synthesis
por: Wang, Jingxuan, et al.
Publicado: (2018)

Enhancing the capability of Klebsiella pneumoniae to produce 1, 3‐propanediol by overexpression and regulation through CRISPR‐dCas9
por: Wang, Xin, et al.
Publicado: (2022)

707. Clarifying the Role of CrrB in Polymxyin-resistant Klebsiella pneumoniae Clinical Isolates Utilizing a Novel CRISPR-Cas9 System
por: McConville, Thomas, et al.
Publicado: (2018)

Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae
por: Lin, Tzu-Lung, et al.
Publicado: (2016)

Coexistence of bla(KPC)-IncFII plasmids and type I-E(*) CRISPR-Cas systems in ST15 Klebsiella pneumoniae
por: Hu, Yiyi, et al.
Publicado: (2023)

Drug Inducible CRISPR/Cas Systems
por: Zhang, Jingfang, et al.
Publicado: (2019)

Correlation of CRISPR/Cas and Antimicrobial Resistance in Klebsiella pneumoniae Clinical Isolates Recovered from Patients in Egypt Compared to Global Strains
por: Alkompoz, Amany K., et al.
Publicado: (2023)

Virulence Genotype and Correlation of Clinical Severeness with Presence of the Type VI Secretion System in Klebsiella pneumoniae Isolates Causing Bloodstream Infections
por: Zhang, Yin, et al.
Publicado: (2022)

Association of CRISPR-Cas System with the Antibiotic Resistance and Virulence Genes in Nosocomial Isolates of Enterococcus
por: Tao, Shuan, et al.
Publicado: (2022)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
por: Lv, Wei, et al.
Publicado: (2021)

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
por: Chen, Yinnan, et al.
Publicado: (2018)

Klebsiella virus UPM2146 lyses multiple drug-resistant Klebsiella pneumoniae in vitro and in vivo
por: Assafiri, Omar, et al.
Publicado: (2021)

Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
por: Liao, Yiqun, et al.
Publicado: (2023)

Detection of Salmonella DNA and drug-resistance mutation by PCR-based CRISPR-lbCas12a system
por: Wang, Shan, et al.
Publicado: (2023)

Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance
por: Duan, Cheng, et al.
Publicado: (2021)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

The Application of the CRISPR-Cas System in Antibiotic Resistance
por: Tao, Shuan, et al.
Publicado: (2022)

Epidemiological Features and Impact of High Glucose Level on Virulence Gene Expression and Serum Resistance of Klebsiella pneumoniae Causing Liver Abscess in Diabetic Patients
por: Tang, Ling, et al.
Publicado: (2023)

Correlation between Drug Resistance of Klebsiella Pneumonia and Antimicrobial Drug Usage
por: Liu, Anyun, et al.
Publicado: (2022)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

The Genetic Structures of an Extensively Drug Resistant (XDR) Klebsiella pneumoniae and Its Plasmids
por: Li, Ling, et al.
Publicado: (2019)

Relationship Between Drug Resistance Characteristics and Biofilm Formation in Klebsiella Pneumoniae Strains
por: Dan, Binzhi, et al.
Publicado: (2023)

One-Pot Isothermal LAMP-CRISPR-Based Assay for Klebsiella pneumoniae Detection
por: Qiu, Xiaotong, et al.
Publicado: (2022)

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
por: Kundar, Rajeshwari, et al.
Publicado: (2022)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
por: Chen, Xia, et al.
Publicado: (2020)

Editorial: The CRISPR/Cas System in Pathogen Resistance, Virulence, Diagnosis and Typing
por: Duan, Guangcai, et al.
Publicado: (2022)

Therapeutic Applications of the CRISPR-Cas System
por: Kang, Kyungmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c866b0n3obu9g577bs6ul3r2fb